Model
Edge
First Wave BioPharma Inc.
FWBI
Filing Type
8-K
Filing Date
10/5/2025
Updated
10/6/25, 2:39 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws, Reg. FD, Other Events
EX-2.1
EXHIBIT 2.1
EX-3.1
EXHIBIT 3.1
EX-10.1
EXHIBIT 10.1
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws, Reg. FD, Other Events